Galectin Therapeutics Inc. is rated a Hold due to absence of finalized agreement with FDA, combined with a tight runway. Read ...

Omeros (OMER) receives FDA approval for Yartemlea (narsoplimab) in TA-TMA, driving shares up nearly 80% to a $1bn+ valuation.

Nebius will also need to take on more debt and sell more shares to fund further data center construction. Investors looking for more attractively valued AI infrastructure stocks should consider this ...

We love 3D printing here, but we also love clean air, which produces a certain tension. There’s no way around the fact that ...

Not for dissemination in the United States or for distribution to U.S. Newswire Services VANCOUVER, British Columbia, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Investing.com -- Stardust Power Inc. (NASDAQ:SDST) stock fell 3.5% Wednesday after the American lithium carbonate developer ...